G1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

G1 Therapeutics

02/08/2023 14:33

* G1 Therapeutics Inc  GTHX.OQ  reported quarterly adjusted
earnings of 14 cents​​ per share for the quarter ended in June.
The mean expectation of eight analysts for the quarter was for a
loss of 22 cents per share.
    * Revenue rose 300.9% to $42.39 million from a year ago;
analysts
expected $28.90 million. 
    * G1 Therapeutics Inc's reported EPS for the quarter was 14
cents​.
    * The mean earnings estimate of analysts had risen by
about 32.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * G1 Therapeutics Inc shares had fallen by 12.0% this
quarter and
lost 59.7% so far this year.
    * The company reported quarterly net income of $8.71
million.
    * Wall Street's median 12-month price target for G1
Therapeutics
Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 01:33 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.22          0.14           Beat
 Mar. 31 2023      -0.64          -0.53          Beat
 Dec. 31 2022      -0.84          -0.73          Beat
 Sep. 30 2022      -0.63          -0.59          Beat